Re: Androgen Receptor Signaling Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer in Japan: The ARASHI Study. Kawahara T. Int J Urol 2025 Oct 15. doi: 10.1111/iju.70259.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kawahara T. Re: Androgen Receptor Signaling Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer in Japan: The ARASHI Study. Int J Urol 2025 Oct 15. doi: 10.1111/iju.70259.
PMID: 41090477